* Encompass Health Corp EHC.N EHC is expected to show a
fall
in quarterly revenue when it reports results on April 27.
* The Birmingham Alabama-based company is expected to
report a
14.2% decrease in revenue to $1.144 billion from $1.33 billion a
year ago, according to the mean estimate from 11 analysts, based
on Refinitiv data.
* Refinitiv's mean analyst estimate for Encompass Health
Corp is
for earnings of 70 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 11 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Encompass
Health
Corp is $70, above its last closing price of $63.34.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2022 0.83 0.83 0.88 Beat 5.8
Sep. 30 2022 0.65 0.64 0.67 Beat 5
Jun. 30 2022 0.92 0.97 0.89 Missed -8
Mar. 31 2022 0.90 0.92 0.97 Beat 5.7
Dec. 1.04 1.05 0.97 Missed -7.5
31 2021
Sep. 30 2021 1.06 1.06 1.03 Missed -2.7
Jun. 30 2021 0.98 0.97 1.17 Beat 20.2
Mar. 31 2021 0.83 0.82 1.05 Beat 27.8
This summary was machine generated April 26 at 02:01 GMT. All
figures in US dollars unless otherwise stated